Synthesis, structural characterization and cytotoxic activity of organotin derivatives of indomethacin

被引:21
作者
Camacho-Camacho, Carlos [1 ]
Rojas-Oviedo, Irma [1 ]
Paz-Sandoval, M. Angeles [2 ]
Cardenas, Jorge [3 ]
Toscano, Alfredo [3 ]
Gielen, Marcel [4 ]
Sosa, Lidia Barron [5 ]
Bartez, Francisco Sanchez [5 ]
Gracia-Mora, Isabel [5 ]
机构
[1] Univ Autonoma Metropolitana Iztapalapa, Dept Sistemas Biol, Mexico City 04960, DF, Mexico
[2] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Quim, Mexico City 07000, DF, Mexico
[3] Univ Nacl Autonoma Mexico, Inst Quim, Mexico City 04510, DF, Mexico
[4] Free Univ Brussels, HNMR Unit, Fac Sci Appl, B-1050 Brussels, Belgium
[5] Univ Circuito Exteriors, Fac Quim Edificio E Cd, Mexico City 04510, DF, Mexico
关键词
organotin; carboxylates; indomethacin; cytotoxic;
D O I
10.1002/aoc.1366
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
The synthesis, characterization and cytotoxic properties in vitro of tri-n-butyltin 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetate (1), tri-phenyltin 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetate (2), tetra-n-butyltin[bis1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetato]distannoxane (3) and di-n-butyltin bis-1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetate (4) are described. These compounds have been characterized by H-1, C-13 and Sn-119 NMR spectroscopy in solution and Sn-119 NMR in the solid state, infrared spectroscopy, elemental analysis and X-ray diffraction for compound 1. The growth inhibition effects of compounds 1-4 against the lung adenocarcinoma cell line SK-LU-1 as well as the cervical cancer cell line HeLa were determined. Compounds 1 and 2 exhibit cytotoxic activity, whereas compounds 3 and 4 are inactive. Copyright (c) 2008 John Wiley & Sons, Ltd.
引用
收藏
页码:171 / 176
页数:6
相关论文
共 35 条
[11]   Organotin compounds and their therapeutic potential: a report from the Organometallic Chemistry Department of the Free University of Brussels [J].
Gielen, M .
APPLIED ORGANOMETALLIC CHEMISTRY, 2002, 16 (09) :481-494
[12]   X-RAY STRUCTURE OF THE DIMERIC BIS[(1,7-DICARBA-CLOSO-DODECABORANE-1-CARBOXYLATO)-DI-N-BUTYLTIN] OXIDE [J].
GIELEN, M ;
BOUHDID, A ;
WILLEM, R ;
BREGADZE, VI ;
ERMANSON, LV ;
TIEKINK, ERT .
JOURNAL OF ORGANOMETALLIC CHEMISTRY, 1995, 501 (1-2) :277-281
[13]   (2-METHYLTHIO-3-PYRIDINECARBOXYLATO)-DIETHYLTIN AND -DI-N-BUTYLTIN COMPOUNDS - SYNTHESIS, SPECTROSCOPIC CHARACTERIZATION AND INVITRO ANTITUMOR-ACTIVITY - X-RAY CRYSTAL-STRUCTURE OF BIS[DIETHYL(2-METHYLTHIO-3-PYRIDINECARBOXYLATO)TIN] OXIDE AND OF DIETHYLTIN BIS(2-METHYLTHIO-3-PYRIDINECARBOXYLATE) [J].
GIELEN, M ;
ELKHLOUFI, A ;
BIESEMANS, M ;
WILLEM, R ;
MEUNIERPIRET, J .
POLYHEDRON, 1992, 11 (15) :1861-1868
[14]   SYNTHESIS, CHARACTERIZATION AND IN-VITRO ANTITUMOR-ACTIVITY OF DIBUTYLTIN CARBOXYLATES INVOLVING THE PERFLUOROPHENYL MOIETY - CRYSTAL-STRUCTURE OF THE DIMERIC BIS[(4-FLUORO-BENZOATO)DI-N-BUTYLTIN] AND PENTAFLUORO-BENZOATO)DI-N-BUTYLTIN] OXIDES [J].
GIELEN, M ;
TIEKINK, ERT ;
BOUHDID, A ;
DEVOS, D ;
BIESEMANS, M ;
VERBRUGGEN, I ;
WILLEM, R .
APPLIED ORGANOMETALLIC CHEMISTRY, 1995, 9 (07) :639-648
[15]  
GIELEN M, 1992, METAL BASED ANTITUMO, V2, P29
[16]  
Gielen M., 2005, METALLOTHERAPEUTIC D, P421, DOI [10.1002/0470864052, DOI 10.1002/0470864052]
[17]  
HAIDUC I, 1999, SUPRAMOLECULAR ORG C, P154
[18]  
HAIDUC I, 1989, ORGANOMETALLICS CANC, V1, P129
[19]  
Kemmer Martine, 1998, Metal-Based Drugs, V5, P189, DOI 10.1155/MBD.1998.189
[20]  
MANHAS BS, 1982, J INDIAN CHEM SOC, V59, P315